These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10816082)

  • 41. [Main epidemiological characteristics of esophageal candidiasis in AIDS (Bordeaux, France 1985-1990. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA)].
    Morlat P; Chène G; Ragnaud JM; Lacoste D; Dupon M; Pellegrin JL
    Presse Med; 1991 Dec 21-28; 20(44):2265. PubMed ID: 1838171
    [No Abstract]   [Full Text] [Related]  

  • 42. Disseminated Mycobacterium avium complex disease in the Swiss HIV Cohort Study: increasing incidence, unchanged prognosis.
    Low N; Pfluger D; Egger M
    AIDS; 1997 Jul; 11(9):1165-71. PubMed ID: 9233465
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disseminated Mycobacterium avium infection among HIV-infected patients in Kenya.
    Gilks CF; Brindle RJ; Mwachari C; Batchelor B; Bwayo J; Kimari J; Arbeit RD; von Reyn CF
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Feb; 8(2):195-8. PubMed ID: 7834402
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mycobacterium avium intracellulare complex infection in HIV-infected children.
    Rutstein RM; Cobb P; McGowan KL; Pinto-Martin J; Starr SE
    AIDS; 1993 Apr; 7(4):507-12. PubMed ID: 8099487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A patient with refractory disseminated Mycobacterium avium after immune-reconstitution localized MAC.
    Jenny-Avital ER
    AIDS Clin Care; 2003 Mar; 15(3):24-6. PubMed ID: 12685419
    [No Abstract]   [Full Text] [Related]  

  • 46. [Isolation of an acid-alcohol resistant bacillus (BAAR) in the febrile HIV infected patients: Mycobacterium tuberculosis (MT) or Mycobacterium avium complex (MAC)?].
    Brel F; Rabaud C; May T; Hoen B; Amiel C; Burty C; Dailloux M; Canton P
    Pathol Biol (Paris); 1995 Apr; 43(4):380-4. PubMed ID: 7567132
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Absolute CD4 count as a predictor for Mycobacterium avium infection in AIDS patients.
    Jordan WC
    J Natl Med Assoc; 1991 Nov; 83(11):943. PubMed ID: 1766014
    [No Abstract]   [Full Text] [Related]  

  • 48. Prospective cohort study of the effect of pregnancy on the progression of human immunodeficiency virus infection. The Groupe d'Epidémiologie Clinique Du SIDA en Aquitaine.
    Hocke C; Morlat P; Chene G; Dequae L; Dabis F
    Obstet Gynecol; 1995 Dec; 86(6):886-91. PubMed ID: 7501333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low incidence of colonization and no cases of disseminated Mycobacterium avium complex infection (DMAC) in Brazilian AIDS patients in the HAART era.
    Gadelha A; Accácio N; Grinzstejn B; Veloso V; da Silveira LB; Fandinho F; Saad MH; Lourenço MC; Rolla V
    Braz J Infect Dis; 2002 Oct; 6(5):252-7. PubMed ID: 12495607
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Identification of Mycobacterium avium-intracellulare complex by PCR of AIDS and disseminated mycobacteriosis].
    García-Elorriaga G; Degollado-Estrada E; Villagómez-Ruiz A; Cortés-Torres N; Arreguín-Reséndiz L; Del Rey-Pineda G; González-Bonilla C
    Rev Med Inst Mex Seguro Soc; 2016; 54(2):170-5. PubMed ID: 26960044
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
    Pierce M; Crampton S; Henry D; Heifets L; LaMarca A; Montecalvo M; Wormser GP; Jablonowski H; Jemsek J; Cynamon M; Yangco BG; Notario G; Craft JC
    N Engl J Med; 1996 Aug; 335(6):384-91. PubMed ID: 8663871
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mycobacterium avium complex-associated cholecystitis in AIDS patient: a case description and review of literature.
    El Chaer F; Harris N; El Sahly H; Hemmige V; Martinez Blanco E; Woc-Colburn L
    Int J STD AIDS; 2016 Nov; 27(13):1218-1222. PubMed ID: 26023092
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictive factors of occurrence of cytomegalovirus disease and impact on survival in the Aquitaine Cohort in France, 1985 to 1994. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    Saillour F; Bernard N; Dequae-Merchadou L; Marimoutou C; Journot V; Dabis F
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Feb; 17(2):171-8. PubMed ID: 9473020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of revision of AIDS case definition. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
    Chêne G; Morlat P; Dabis F
    Lancet; 1992 May; 339(8804):1298-9. PubMed ID: 1349695
    [No Abstract]   [Full Text] [Related]  

  • 55. Clarithromycin resistance and susceptibility patterns of Mycobacterium avium strains isolated during prophylaxis for disseminated infection in patients with AIDS.
    Craft JC; Notario GF; Grosset JH; Heifets LB
    Clin Infect Dis; 1998 Oct; 27(4):807-12. PubMed ID: 9798037
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disseminated Mycobacterium avium complex infection: clinical identification and epidemiologic trends.
    Havlik JA; Horsburgh CR; Metchock B; Williams PP; Fann SA; Thompson SE
    J Infect Dis; 1992 Mar; 165(3):577-80. PubMed ID: 1347060
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis.
    Jung Y; Song KH; Choe PG; Park WB; Bang JH; Kim ES; Kim HB; Park SW; Kim NJ; Oh MD
    Int J STD AIDS; 2017 Dec; 28(14):1426-1432. PubMed ID: 28592210
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mycobacterium avium complex and HIV.
    Chaisson RE
    J Int Assoc Physicians AIDS Care; 1995 Aug; 1(7):10-5. PubMed ID: 11362745
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD4+ T cells but Not CD8+ or gammadelta+ lymphocytes are required for host protection against Mycobacterium avium infection and dissemination through the intestinal route.
    Petrofsky M; Bermudez LE
    Infect Immun; 2005 May; 73(5):2621-7. PubMed ID: 15845464
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy.
    Kirk O; Reiss P; Uberti-Foppa C; Bickel M; Gerstoft J; Pradier C; Wit FW; Ledergerber B; Lundgren JD; Furrer H;
    Ann Intern Med; 2002 Aug; 137(4):239-50. PubMed ID: 12186514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.